Advertisement

Influence of Gender on Outcome of Severe Sepsis

  • C. Adrie
  • E. Azoulay
  • J. -F. Timsit

Abstract

Whether gender influences the outcome of severe sepsis remains a matter of debate. Because many confounding variables may affect observed associations between gender and mortality, high-quality statistical analyses are essential to carefully adjust the two groups of patients. About 55% to 65% of patients with sepsis have chronic co-morbidities associated with immune dysfunction (e.g., chronic renal failure, diabetes mellitus, human immunodeficiency virus [HIV] infection, and alcohol abuse), which increase the susceptibility to sepsis [1]. Genetic polymorphisms that affect the susceptibility to infection and/or the severity of the systemic response to infection [2] may lead to variability among individuals and between males and females [3]. Access to healthcare, another determinant of the incidence and outcome of sepsis, varies according to age, ethnic group, and gender, although a recent study conducted in the USA found only relatively small quality-of-care differences between males and females or across income groups compared to the gap for each subgroup between observed and desirable quality of health care [4]. Here, we review the data on the existence of, and reasons for, associations between gender and outcome of severe sepsis (Fig. 1).

Keywords

Severe Sepsis Acute Lung Injury Aromatase Activity Lipopolysaccharide Binding Protein Serum Estradiol Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS (2006) The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 34:2576–2582PubMedCrossRefGoogle Scholar
  2. 2.
    Arcaroli J, Fessler MB, Abraham E (2005) Genetic polymorphisms and sepsis. Shock 24:300–312PubMedCrossRefGoogle Scholar
  3. 3.
    Schroder J, Kahlke V, Book M, Stuber F (2000) Gender differences in sepsis: genetically determined? Shock 14:307–310PubMedCrossRefGoogle Scholar
  4. 4.
    Asch SM, Kerr EA, Keesey J, et al (2006) Who is at greatest risk for receiving poor-quality health care? N Engl J Med 354:1147–1156PubMedCrossRefGoogle Scholar
  5. 5.
    Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRefGoogle Scholar
  6. 6.
    Adrie C, Alberti C, Chaix-Couturier C, et al (2005) Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 20:46–58PubMedCrossRefGoogle Scholar
  7. 7.
    Wichmann MW, Inthorn D, Andress HJ, Schildberg FW (2000) Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167–172PubMedCrossRefGoogle Scholar
  8. 8.
    Offner PJ, Moore EE, Biffl WL (1999) Male gender is a risk factor for major infections after surgery. Arch Surg 134:935–938PubMedCrossRefGoogle Scholar
  9. 9.
    Moss M, Mannino DM (2002) Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979–1996). Crit Care Med 30:1679–1685PubMedCrossRefGoogle Scholar
  10. 10.
    Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, and Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310.PubMedCrossRefGoogle Scholar
  11. 11.
    Schroder J, Kahlke V, Staubach KH, Zabel P, and Stuber F (1998) Gender differences in human sepsis. Arch Surg 133:1200–1205PubMedCrossRefGoogle Scholar
  12. 12.
    Oberholzer A, Keel M, Zellweger R, Steckholzer U, Trentz O, and Ertel W (2000) Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 48:932–937PubMedGoogle Scholar
  13. 13.
    Mostafa G, Huynh T, Sing RF, Miles WS, Norton HJ, and Thomason MH (2002) Gender-related outcomes in trauma. J Trauma 53:430–434PubMedGoogle Scholar
  14. 14.
    Gannon CJ, Pasquale M, Tracy JK, McCarter RJ, and Napolitano LM (2004) Male gender is associated with increased risk for postinjury pneumonia. Shock 21:410–414PubMedCrossRefGoogle Scholar
  15. 15.
    Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG (1999) Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 282:2143–2148PubMedCrossRefGoogle Scholar
  16. 16.
    Bindl L, Buderus S, Dahlem P, et al (2003) Gender-based differences in children with sepsis and ARDS: the ESPNIC ARDS Database Group. Intensive Care Med 29:1770–1773PubMedCrossRefGoogle Scholar
  17. 17.
    George RL, McGwin G Jr, Schwacha MG, et al (2005) The association between sex and mortality among burn patients as modified by age. J Burn Care Rehabil 26:416–421PubMedCrossRefGoogle Scholar
  18. 18.
    Eachempati SR, Hydo L, Barie PS (1999) Gender-based differences in outcome in patients with sepsis. Arch Surg 134:1342–1347PubMedCrossRefGoogle Scholar
  19. 19.
    Adrie C, Francais A, Garrouste-Orgeas M, et al (2006) Sex gender influences the outcome of severe sepsis. Intensive Care Med 32:S0309 (abst)CrossRefGoogle Scholar
  20. 20.
    Kher A, Wang M, Tsai BM, et al (2005) Sex differences in the myocardial inflammatory response to acute injury. Shock 23:1–10PubMedCrossRefGoogle Scholar
  21. 21.
    Hubacek JA, Stuber F, Frohlich D, et al (2001) Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 29:557–561PubMedCrossRefGoogle Scholar
  22. 22.
    Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106–110PubMedCrossRefGoogle Scholar
  23. 23.
    Knoferl MW, Angele MK, Catania RA, Diodato MD, Bland KI, Chaudry IH (2003) Immuno-modulatory effects of dehydroepiandrosterone in proestrus female mice after trauma-hemorrhage. J Appl Physiol 95:529–535PubMedGoogle Scholar
  24. 24.
    Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH (2001) Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 14:162–169PubMedCrossRefGoogle Scholar
  25. 25.
    Kuebler JF, Jarrar D, Toth B, et al (2002) Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137:74–79PubMedCrossRefGoogle Scholar
  26. 26.
    Angele MK, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH (1997) Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 132:1207–1214PubMedGoogle Scholar
  27. 27.
    Angele MK, Catania RA, Ayala A, Cioffi WG, Bland KI, Chaudry IH (1998) Dehydroepian-drosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhage. Arch Surg 133:1281–1288PubMedCrossRefGoogle Scholar
  28. 28.
    Imahara SD, Jelacic S, Junker CE, O’Keefe GE (2005) The influence of gender on human innate immunity. Surgery 138:275–282PubMedCrossRefGoogle Scholar
  29. 29.
    Tsai BM, Wang M, Pitcher JM, Kher A, Brown JW, Meldrum DR (2005) Endothelium-dependent pulmonary artery vasorelaxation is dysfunctional in males but not females after acute lung injury. Surgery 138:78–84PubMedCrossRefGoogle Scholar
  30. 30.
    Cristofaro PA, Opal SM, Palardy JE, et al (2006) WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med 34:2188–2193.PubMedCrossRefGoogle Scholar
  31. 31.
    Angstwurm MW, Gaertner R, Schopohl J (2005) Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med 33:2786–2793PubMedCrossRefGoogle Scholar
  32. 32.
    Nalbandian G, Kovats S (2005) Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 31:91–106PubMedCrossRefGoogle Scholar
  33. 33.
    Adamski J, Ma Z, Nozell S, Benveniste EN (2004) 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol Endocrinol 18:1963–1974PubMedCrossRefGoogle Scholar
  34. 34.
    Adamski J, Benveniste EN (2005) 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression. Mol Endocrinol 19:113–124PubMedCrossRefGoogle Scholar
  35. 35.
    Pellegrino TC and Bayer BM (2002) Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav Immun 16:87–103PubMedCrossRefGoogle Scholar
  36. 36.
    Narita J, Miyaji C, Watanabe H, et al (1998) Differentiation of forbidden T cell clones and granulocytes in the parenchymal space of the liver in mice treated with estrogen. Cell Immunol 185:1–13PubMedCrossRefGoogle Scholar
  37. 37.
    Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM (2003) Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 15:233–240PubMedCrossRefGoogle Scholar
  38. 38.
    Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL (2005) An over-looked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health 5:1–10CrossRefGoogle Scholar
  39. 39.
    Esmon CT (2003) Coagulation and inflammation. J Endotoxin Res 9:192–198PubMedGoogle Scholar
  40. 40.
    Federman DD (2006) The biology of human sex differences. N Engl J Med 354:1507–1514PubMedCrossRefGoogle Scholar
  41. 41.
    Sharma AC, Bosmann HB, Motew SJ, Hales KH, Hales DB, Ferguson JL (1996) Steroid hormone alterations following induction of chronic intraperitoneal sepsis in male rats. Shock 6:150–154PubMedCrossRefGoogle Scholar
  42. 42.
    Sam AD, 2nd, Sharma AC, Lee LY, et al (1999) Sepsis produces depression of testosterone and steroidogenic acute regulatory (StAR) protein. Shock 11:298–301PubMedCrossRefGoogle Scholar
  43. 43.
    Mechanick JI, Nierman DM (2006) Gonadal steroids in critical illness. Crit Care Clin 22: 87–103PubMedCrossRefGoogle Scholar
  44. 44.
    Zhao Y, Nichols JE, Valdez R, Mendelson CR, Simpson ER (1996) Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol 10:1350–1357PubMedCrossRefGoogle Scholar
  45. 45.
    Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchick MW, Reed MJ (1994) Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol Cell Endocrinol 106:17–21PubMedCrossRefGoogle Scholar
  46. 46.
    Seli E, Arici A (2002) Sex steroids and the immune system. Immunol Allergy Clin N Am 22:407–408CrossRefGoogle Scholar
  47. 47.
    Lee HJ, Chang C (2003) Recent advances in androgen receptor action. Cell Mol Life Sci 60:1613–22PubMedCrossRefGoogle Scholar
  48. 48.
    Krucken J, Dkhil MA, Braun JV, et al (2005) Testosterone suppresses protective responses of the liver to blood-stage malaria. Infect Immun 73:436–43PubMedCrossRefGoogle Scholar
  49. 49.
    Angele MK, Nitsch S, Knoferl MW, et al (2003) Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol. Am Physiol Endocrinol Metab 285:E189–196Google Scholar
  50. 50.
    Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801–1811PubMedCrossRefGoogle Scholar
  51. 51.
    Messer G, Spengler U, Jung MC, et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209–219PubMedCrossRefGoogle Scholar
  52. 52.
    Arcaroli J, Silva E, Maloney JP, et al (2006) Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173:1335–1341PubMedCrossRefGoogle Scholar
  53. 53.
    Kerr EA, McGlynn EA, Adams J, Keesey J, Asch SM (2004) Profiling the quality of care in twelve communities: results from the CQI study. Health Aff (Millwood) 23:247–256CrossRefGoogle Scholar
  54. 54.
    McGlynn EA, Asch SM, Adams J, et al (2003) The quality of health care delivered to adults in the United States. N Engl J Med 348:2635–2645PubMedCrossRefGoogle Scholar
  55. 55.
    Redberg RF (2005) Gender, race, and cardiac care: why the differences? J Am Coll Cardiol 46:1852–1854PubMedCrossRefGoogle Scholar
  56. 56.
    Jaglal SB, Goel V, Naylor CD (1994) Sex differences in the use of invasive coronary procedures in Ontario. Can J Cardiol 10:239–244PubMedGoogle Scholar
  57. 57.
    Ayanian JZ, Epstein AM (1991) Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 325:221–225PubMedCrossRefGoogle Scholar
  58. 58.
    Vaccarino V, Rathore SS, Wenger NK, et al (2005) Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 353:671–682PubMedCrossRefGoogle Scholar
  59. 59.
    Valentin A, Jordan B, Lang T, Hiesmayr M, Metnitz PG (2003) Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patients. Crit Care Med 31:1901–1907PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • C. Adrie
    • 1
  • E. Azoulay
    • 2
  • J. -F. Timsit
    • 3
  1. 1.Medical-Surgical Intensive Care UnitDelafontaine HospitalSaint DenisFrance
  2. 2.Medical Intensive Care UnitHôpital St LouisParisFrance
  3. 3.Medical Intensive Care UnitHôpital MichallonGrenobleFrance

Personalised recommendations